We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Suction Holds Tissue Stabilizer on Heart

By HospiMedica staff writers
Posted on 07 Aug 2006
An innovative cardiac surgery instrument enables heart surgeons to stabilize the area in the heart while working on it.

The Octopus Evolution tissue stabilizer is intended for use in beating-heart surgery. More...
The stabilizer includes suction pods that hold the surface tissue of the heart stable while the surgeon attaches a transplanted vessel around blockages in the coronary arteries. The device can be easily positioned on any target area of the heart surface, stabilizing the suture site to a degree unattainable before, and enabling the surgeon to continue working with an unimpeded view as the vessel is sutured in place.

The tissue stabilizers' malleable stabilizer pods can be formed to the unique contours of the patient's anatomy, and a unique tissue-spreading mechanism enhances stabilization of the anastomotic site and presentation of the coronary artery. The stabilizer was developed by Medtronic (Minneapolis, MN, USA).

The tissue stabilizer is part of the Medtronic Octopus system that is designed to maximize access and stabilization of coronary arteries for off-pump grafting. The system also includes the OctoBase retractor, which allows multiple mounting options, the Starfish heart positioner, with an integrated bellows suspension that allows for natural heart movement throughout the cardiac cycle, and a three-appendage silicone head design that allows for multiple attachment options to optimize placement on the epicardium.

Conventional coronary artery bypass (CCABG) necessitates the use of a heart-lung machine to pump and oxygenate the patient's blood while the heart is stopped.



Related Links:
Medtronic

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.